Snowflake surges 24% as tech premarket splits on AI delivery versus AI promise
Technology premarket trading carved a clear divide between companies delivering AI revenue now and those projecting it later. Snowflake (SNOW) surged 24% after beating second-quarter expectations and raising its full-year product…
Key takeaways
- Snowflake surged 24% in premarket trading after beating second-quarter expectations and raising its full-year product revenue forecast on AI-driven revenue acceleration.
- Broadcom fell 3% despite projecting a boom in AI chip sales over the next two years, as markets treated its near-term results and outlook as falling short.
- The Snowflake–Broadcom divergence shows markets rewarding demonstrated AI monetization over forward-looking scale guidance in the AI capex cycle.
- Ultragenyx Pharmaceutical plunged 44% after an experimental drug for a rare genetic disorder failed its primary study endpoint, prompting multiple analyst downgrades.
- Several companies fell despite positive news, including NetApp (-8%) and Victoria's Secret (-18%), both of which had raised guidance.
Technology premarket trading carved a clear divide between companies delivering AI revenue now and those projecting it later. Snowflake (SNOW) surged 24% after beating second-quarter expectations and raising its full-year product revenue forecast, with analysts pointing to AI-driven revenue acceleration as the driver. Broadcom (AVGO) fell 3% despite projecting a boom in artificial intelligence chip sales over the next two years, as markets treated the near-term results and outlook as falling short.
The divergence between Snowflake and Broadcom runs along the fault line defining the technology sector's current position in the AI capex cycle. Snowflake's move reflects a market rewarding demonstrated monetization over forward narrative. Broadcom's decline, against the backdrop of a two-year buildout story the company itself supplied, shows that scale guidance alone is no longer enough to hold a stock on earnings day. Hewlett Packard Enterprise (HPE) reinforced that read, dropping 4% after sales growth missed investor expectations.
On the software side of the AI trade, Meta Platforms rose 0.7% after releasing its latest artificial intelligence model. Microsoft (MSFT) climbed 0.5%, Alphabet (GOOGL) added 0.3%, and Amazon (AMZN) rose 0.2%. Nvidia (NVDA) slipped 0.4% and Apple (AAPL) fell 0.2%, moves consistent with a session offering no single directional signal. Tesla (TSLA) gained 1.2%.
Sector-wide stress outside the AI narrative
The session carried idiosyncratic pressure well beyond the technology complex. Ultragenyx Pharmaceutical (RARE) plunged 44% after an experimental drug for a rare genetic disorder failed its primary study endpoint, prompting multiple analyst downgrades. Advasa (ADBT) fell 11% following the resignation of CFO Katharyn Field.
NetApp (NTAP) dropped 8% despite raising its full-year forecast, a move that reads partly as profit-taking after a year-to-date rally of nearly 70%. Victoria's Secret (VSXY) fell 18% even as the company raised its guidance, with the market focused on the slower pace of growth rather than the revised targets. Campbell Soup (CPB) slipped 5% after cutting its dividend and issuing guidance that disappointed. Argan (AGX) ran 6% higher after second-quarter revenue exceeded analyst estimates. JPMorgan's upgrade of Envista (NVST) to overweight, citing improved execution ahead of the company's investor day, lifted that stock 2%. Ciena (CIEN) added 1% on its third-quarter earnings report.
On balance, the session's clearest macro signal sits with Broadcom. If a company projecting sector-wide AI chip demand over two years cannot hold its ground on earnings day, the capex cycle's near-term demand environment is running well behind the scale of the investment narrative being built around it.